Back to Newsroom

ProMIS Neurosciences Issues Response to Recent Market Activity

TORONTO and CAMBRIDGE, MAJan. 22, 2017 /PRNewswire/ – At the request of IIROC (“Investment Industry Regulatory Organization of Canada“), ProMIS Neurosciences Inc. (TSX: PMN) (OTCQB: ARFXF) (the “Company”) wishes to confirm that it is not aware of any material, undisclosed information related to the Company that would account for the recent increase in the market price and level of trading volume of its ordinary shares.